KIORA PHARMACEUTICALS INC

Analysis for Ticker: KPRX

Kiora Pharmaceuticals develops drugs for rare eye diseases like retinitis pigmentosa that cause people to go blind. But the business is a mathematical ghost. By 12/2025, the company had burned through 154 million$ and generated exactly 0$ in product revenue. The core crime is a machine designed to extract cash from investors to fund an executive lifestyle while the underlying enterprise slowly dies. It is like a piggy bank where regular people keep putting their money, but the people running the bank have drilled a hole in the bottom to pay themselves bonuses and taxes, ensuring the bank is always nearly empty for the actual owners.